Interference of preceding BCG vaccination with BCG immunotherapy in L2C-guinea pig leukemia. 1977

H D Dopatka, and M Majer, and W Hennessen, and R Mauler

Guinea pigs of inbred strain 2 were vaccinated with BCG 1331 Copenhagen (K-Nr. 240-1) six to seven weeks before intradermal application of about 10(5) leukocytes from a highly leukemic animal in mixture with 10(7) colony forming units (CFU) of BCG. This presensitization with BCG totally abolished or strongly reduced the antitumor activity of L2C-cells adjoining BCG. Increase of bacterial mass applied from 1 X 10(7) to 2 X 10(8) CFU did not restore the antileukemic effect of BCG as observed in unvaccinated guinea pigs by a significant delay of death in a portion of animals and by the occurrence of long-term survivors. Since local reaction to BCG occurred much earlier in presensitized than in unvaccinated animals, we speculate that the destruction of tumor cells and hence the antigenic stimulus was too premature in presensitized animals to build up a BCG-mediated antitumor immunity.

UI MeSH Term Description Entries
D007942 Leukemia, Experimental Leukemia induced experimentally in animals by exposure to leukemogenic agents, such as VIRUSES; RADIATION; or by TRANSPLANTATION of leukemic tissues. Experimental Leukemia,Experimental Leukemias,Leukemia Model, Animal,Leukemias, Experimental,Animal Leukemia Model,Animal Leukemia Models,Leukemia Models, Animal
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001500 BCG Vaccine An active immunizing agent and a viable avirulent attenuated strain of MYCOBACTERIUM BOVIS, which confers immunity to mycobacterial infections. It is used also in immunotherapy of neoplasms due to its stimulation of antibodies and non-specific immunity. Bacillus Calmette Guerin Vaccine,Calmette Guerin Bacillus Vaccine,Calmette's Vaccine,Calmette Vaccine,Calmettes Vaccine,Vaccine, BCG,Vaccine, Calmette's

Related Publications

H D Dopatka, and M Majer, and W Hennessen, and R Mauler
September 1971, Cancer,
H D Dopatka, and M Majer, and W Hennessen, and R Mauler
August 1977, Federation proceedings,
H D Dopatka, and M Majer, and W Hennessen, and R Mauler
January 1972, Blood,
H D Dopatka, and M Majer, and W Hennessen, and R Mauler
August 1977, Federation proceedings,
H D Dopatka, and M Majer, and W Hennessen, and R Mauler
February 1986, Nihon Ika Daigaku zasshi,
H D Dopatka, and M Majer, and W Hennessen, and R Mauler
October 1974, Cancer,
H D Dopatka, and M Majer, and W Hennessen, and R Mauler
January 1974, Johns Hopkins medical journal. Supplement,
H D Dopatka, and M Majer, and W Hennessen, and R Mauler
April 1979, The American journal of pathology,
H D Dopatka, and M Majer, and W Hennessen, and R Mauler
August 1977, Federation proceedings,
H D Dopatka, and M Majer, and W Hennessen, and R Mauler
June 1967, Journal of the National Cancer Institute,
Copied contents to your clipboard!